1-(Tetrahydro-2H-pyran-4-yl)-8-[3-(trifluoromethoxy)phenyl][1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA4878956

PubChem CID: 164628361

Max Phase: Preclinical

Molecular Formula: C21H17F3N4O2

Molecular Weight: 414.39

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  FC(F)(F)Oc1cccc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1

Standard InChI:  InChI=1S/C21H17F3N4O2/c22-21(23,24)30-16-3-1-2-14(10-16)15-4-5-17-18(11-15)28-19(12-25-17)26-27-20(28)13-6-8-29-9-7-13/h1-5,10-13H,6-9H2

Standard InChI Key:  LVDVUOBGQYBTCL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   10.7844  -10.2479    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.1972   -9.5422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3796   -9.5376    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.3295  -12.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3284  -13.2342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0406  -13.6473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0388  -12.0017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7515  -12.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7523  -13.2301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4649  -13.6413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1773  -13.2263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4594  -11.9967    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1715  -12.3972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7712  -11.8434    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4338  -11.1032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6215  -11.1955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0651  -10.5919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3170   -9.8080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7645   -9.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9614   -9.3758    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7136  -10.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2649  -10.7705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6197  -12.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6208  -11.1799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9097  -10.7674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2011  -11.1803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2039  -12.0059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9115  -12.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9089   -9.9502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1999   -8.7251    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 13  1  0
 12  8  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 16 17  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
  4 23  1  0
 25 29  1  0
 29  2  1  0
  2 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4878956

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 414.39

Molecular Weight (Monoisotopic): 414.1304

AlogP: 4.74

#Rotatable Bonds: 3

Polar Surface Area: 61.54

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.00

CX LogP: 3.61

CX LogD: 3.61

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.48

Np Likeness Score: -1.29

References

1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G..  (2021)  BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.,  64  (17.0): [PMID:34428039] [10.1021/acs.jmedchem.1c00762]

Source

Source(1):

• Scientific Literature